<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000562655"><TermName>Hytrin</TermName><TermPronunciation>(HY-trin)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat urinary problems caused by an enlarged prostate. It is also used to treat high blood pressure and is being studied in the treatment of other conditions. Hytrin relaxes muscle tissue in blood vessels and in the prostate. It is a type of alpha blocker. Also called terazosin and terazosin hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000721060" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Hytrin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000721059" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Hytrin&quot;" language="es" id="_4"/><SpanishTermName>Hytrin</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar los problemas urinarios a causa de una próstata agrandada. Asimismo, se usa para tratar la presión arterial alta y está en estudio para el tratamiento de otras afecciones. Hytrin relaja el tejido muscular de los vasos sanguíneos y la próstata. Es un tipo de bloqueador alfa. También se llama clorhidrato de terazosina y terazosina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-08-20</DateFirstPublished></GlossaryTerm>
